We are live on
!
Find out more
HC
Henshaw Capital Portfolio holdings
AUM
$3.07B
Turnover
11.76%
1-Year Est. Return
40.85%
This Fund
S&P 500
This Quarter
Est. Return
+5.32%
1 Year Est. Return
+40.85%
3 Year Est. Return
+128.2%
5 Year Est. Return
+170.36%
10 Year Est. Return
+567.65%
AUM
$977M
AUM Growth
+$21.3M
(+2.2%)
Cap. Flow
-$22.1M
Cap. Flow
% of AUM
-2.26%
Top 10 Holdings %
Top 10 Hldgs %
33.97%
Holding
324
New
40
Increased
71
Reduced
47
Closed
54
Avg Time Held
0.9
years
Top 10 Avg Time Held
1.4
years
Top 20 Avg Time Held
1.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Aflac
AFL
|
+$6.76M |
| 2 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$4.98M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$4.3M |
| 4 |
JPMorgan Chase
JPM
|
+$3.24M |
| 5 |
Occidental Petroleum
OXY
|
+$3.04M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESRX
Express Scripts Holding Company
ESRX
|
+$11.8M |
| 2 |
HCA Healthcare
HCA
|
+$9.33M |
| 3 |
Teva Pharmaceutical Industries Limited
TEVA
|
+$8.94M |
| 4 |
SLB Ltd
SLB
|
+$7.72M |
| 5 |
Hess
HES
|
+$4.34M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 18.55% |
| 2 | Technology | 16.96% |
| 3 | Communication Services | 13.04% |
| 4 | Financials | 12.25% |
| 5 | Healthcare | 10.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
226
Korn Ferry
KFY
$4.09B
| $305K | 0.03% |
7,740
| – | – |
2016 Q4
3 quarters
|
|
|
TIVO
227
DELISTED
Tivo Inc
TIVO
| $305K | 0.03% |
15,356
+3,515
| +30% | +$65.7K |
2017 Q2
1 quarter
|
|
228
RLJ Lodging Trust
RLJ
$1.77B
| $304K | 0.03% |
+13,808
| New | +$284K |
2017 Q3
0 quarters
|
|
|
TVTY
229
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $303K | 0.03% |
7,427
| – | – |
2017 Q2
1 quarter
|
|
|
CYOU
230
DELISTED
Changyou.com Limited American Depositary Share
CYOU
| $299K | 0.03% |
+7,552
| New | +$304K |
2017 Q3
0 quarters
|
|
231
Globus Medical
GMED
$10.6B
| $297K | 0.03% |
10,005
| – | – |
2017 Q2
1 quarter
|
|
232
Grupo Cibest SA
CIB
$23.1B
| $297K | 0.03% |
+6,478
| New | +$292K |
2017 Q3
0 quarters
|
|
|
LKSD
233
DELISTED
LSC Communications, Inc.
LKSD
| $296K | 0.03% |
17,955
| – | – |
2017 Q2
1 quarter
|
|
234
Danaher
DHR
$163B
| $294K | 0.03% |
+3,865
| New | +$286K |
2017 Q3
0 quarters
|
|
235
MetLife
MET
$63.7B
| $292K | 0.03% |
+5,620
| New | +$274K |
2017 Q3
0 quarters
|
|
236
MakeMyTrip
MMYT
$4.4B
| $291K | 0.03% |
+10,137
| New | +$324K |
2017 Q3
0 quarters
|
|
237
DELISTED
Randgold Resources Ltd
GOLD
| $290K | 0.03% |
+2,968
| New | +$285K |
2017 Q3
0 quarters
|
|
238
Infosys
INFY
$49.1B
| $284K | 0.03% |
+38,936
| New | +$295K |
2017 Q3
0 quarters
|
|
239
ICICI Bank
IBN
$106B
| $283K | 0.03% |
33,031
+13,670
| +71% | +$125K |
2016 Q1
6 quarters
|
|
240
Bank OZK
OZK
$5B
| $282K | 0.03% |
5,869
| – | – |
2016 Q1
6 quarters
|
|
241
Amkor Technology
AMKR
$10.9B
| $276K | 0.03% |
+26,136
| New | +$250K |
2017 Q3
0 quarters
|
|
242
Suncor Energy
SU
$88.5B
| $273K | 0.03% |
7,788
-7,647
| -50% | -$244K |
2016 Q1
6 quarters
|
|
243
Banco de Chile
BCH
$19.7B
| $272K | 0.03% |
+9,143
| New | +$257K |
2017 Q3
0 quarters
|
|
244
DELISTED
Civitas Solutions, Inc.
CIVI
| $270K | 0.03% |
14,631
| – | – |
2017 Q2
1 quarter
|
|
245
AMN Healthcare
AMN
$1.55B
| $268K | 0.03% |
5,859
| – | – |
2017 Q2
1 quarter
|
|
246
EPR Properties
EPR
$4.22B
| $265K | 0.03% |
3,800
| – | – |
2017 Q2
1 quarter
|
|
247
Ultrapar
UGP
$8.14B
| $262K | 0.03% |
+22,012
| New | +$259K |
2017 Q3
0 quarters
|
|
248
McKesson
MCK
$116B
| $262K | 0.03% |
+1,703
| New | +$266K |
2017 Q3
0 quarters
|
|
249
Duke Energy
DUK
$92.7B
| $261K | 0.03% |
+3,113
| New | +$267K |
2017 Q3
0 quarters
|
|
250
Sony
SONY
$144B
| $259K | 0.03% |
34,655
-6,455
| -16% | -$50.6K |
2016 Q1
6 quarters
|
|
Similar funds
Henshaw Capital's Q3 2017 Portfolio in Review
As of Q3 2017, Henshaw Capital held 324 positions worth $977M, up 2.2% from $955M the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Henshaw Capital's Q3 2017 filing shows 40 new, 71 increased, 47 reduced and 54 closed positions. Its largest new stake was Philip Morris: 7,362 shares worth $817K. The largest sale was Express Scripts Holding Company, an estimated $11.8M.
By sector, the portfolio is most concentrated in Industrials at 19% of assets, up from 18% a quarter earlier, followed by Technology and Communication Services.
- Henshaw Capital's largest Q3 2017 buy was Philip Morris: 7,362 shares worth $817K.
- Henshaw Capital added most to Aflac in Q3 2017, an estimated $6.76M increase.
- Henshaw Capital's biggest Q3 2017 reduction was HCA Healthcare, cutting an estimated $9.33M.
- Henshaw Capital fully exited Express Scripts Holding Company in Q3 2017, selling an estimated $11.8M.
- Henshaw Capital's ten largest holdings make up 34% of its $977M portfolio in Q3 2017.
- Henshaw Capital opened 40 new positions and closed 54 in Q3 2017.
- Henshaw Capital's portfolio value rose 2.2% quarter-over-quarter to $977M.
Based on Henshaw Capital's 13F filing for Q3 2017, filed 28 May 2026.